Drug Profile
C 8500
Alternative Names: C-8500Latest Information Update: 18 Feb 2008
Price :
$50
*
At a glance
- Originator Merck & Co
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Osteoporosis
Most Recent Events
- 31 Aug 2005 Phase-I clinical trials in Osteoporosis in USA (unspecified route)